Global Pressure Ulcers Treatment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Treatment Type;
Wound Care Dressings - Antimicrobial Dressings, Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings & Other Dressings, Wound Care Devices - Negative Pressure Wound Therapy (NPWT), Ultrasound Therapy & Others (HBOT and electromagnetic therapy), Active Therapies - Skin Grafts & Substitutes, Growth Factors, Others (hemostatic agents and sealants (collagen & fibrin sealants)), Others - Traditional Wound Care Products, Pressure Relief Devices, and Others.By Type of Wound;
Stage 1, Stage 2, Stage 3, and Stage 4.By End Users;
Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers, and Home Health Care.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Pressure Ulcers Treatment Market (USD Million), 2021 - 2031
In the year 2024, the Global Pressure Ulcers Treatment Market was valued at USD 21,339.12 million. The size of this market is expected to increase to USD 29,667.82 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.
The global pressure ulcers treatment market represents a dynamic landscape within the healthcare sector, fueled by the persistent need for effective solutions to manage and prevent pressure ulcers, also known as bedsores or pressure sores. Pressure ulcers pose significant challenges to patients' quality of life and healthcare systems worldwide, particularly affecting individuals with limited mobility, such as the elderly or those with chronic illnesses. These wounds develop due to prolonged pressure on the skin, often occurring in bony areas like the hips, heels, and tailbone, leading to tissue damage and, in severe cases, infections. As a result, the demand for innovative treatment modalities and preventive measures continues to drive the expansion of the global pressure ulcers treatment market.
In recent years, technological advancements and a growing emphasis on patient-centric care have spurred the development of novel approaches to pressure ulcer management. This includes the introduction of advanced wound care products, such as dressings, negative pressure wound therapy (NPWT) systems, and support surfaces like specialized mattresses and cushions designed to reduce pressure and friction. Additionally, healthcare providers are increasingly adopting evidence-based guidelines and protocols for pressure ulcer prevention and treatment, driving market growth further. Moreover, the rising prevalence of chronic conditions, such as diabetes and obesity, underscores the importance of comprehensive pressure ulcer management strategies, contributing to the market's expansion.
The global pressure ulcers treatment market is characterized by a diverse competitive landscape, with key players ranging from medical device manufacturers to pharmaceutical companies and healthcare service providers. These stakeholders are continually investing in research and development initiatives to introduce innovative products and therapies aimed at addressing unmet clinical needs and improving patient outcomes. Furthermore, strategic collaborations, mergers, and acquisitions are common strategies employed by market players to enhance their product portfolios and expand their market presence. With an aging population and increasing healthcare expenditure worldwide, the pressure ulcers treatment market is poised for sustained growth as healthcare systems strive to meet the evolving needs of patients and improve the standard of care for pressure ulcer management globally.
Global Pressure Ulcers Treatment Market Recent Developments
-
In March 2019, Smith & Nephew plc, a U.K.-based medical technology company, agreed to acquire Osiris Therapeutics, a fast-growing company delivering regenerative medicine products, including skin, bone graft, and articular cartilage substitutes, for US$ 19.00 per share in cash, representing a total equity value of around US$ 660 Mn.
-
In January 2019, Mölnlycke Health Care AB announced the acquisition of M&J Airlaid Products A/S (“M&J”). M&J is a Denmark-based private company and manufacturer of specialized and high-quality absorbent Airlaid nonwoven materials. M&J’s Airlaid technology is critical, along with foams and soft silicone, in Mölnlycke’s wound care products.
Segment Analysis
This report extensively covers different segments of Global Pressure Ulcers Treatment Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments.
The global pressure ulcers treatment market can be dissected into various segments based on treatment type, type of wound, end-users, and geography, providing a comprehensive view of its dynamics and opportunities. In terms of treatment type, the market encompasses a wide array of options, including wound care dressings like antimicrobial dressings, foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings, and other dressings. Additionally, wound care devices such as negative pressure wound therapy (NPWT), ultrasound therapy, and other modalities like hyperbaric oxygen therapy (HBOT) and electromagnetic therapy play pivotal roles in managing pressure ulcers. Furthermore, active therapies like skin grafts and substitutes, growth factors, and other innovative approaches like hemostatic agents and sealants contribute significantly to the treatment landscape.
Segmentation by type of wound further refines the market analysis, categorizing pressure ulcers into stages 1 through 4 based on their severity and depth. This segmentation allows for tailored treatment approaches, ensuring optimal care for patients at each stage of ulcer development. Moreover, considering the diverse healthcare settings where pressure ulcer treatment occurs, the market is segmented by end-users, including hospital inpatient settings, hospital outpatient settings, community health centers, and home health care facilities. Each of these settings presents unique challenges and opportunities in pressure ulcer management, influencing the adoption of specific treatment modalities and products.
Geographically, the global pressure ulcers treatment market spans across major regions such as North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, each characterized by its healthcare infrastructure, regulatory environment, and prevalence of pressure ulcers. Understanding regional variations is crucial for market players to tailor their strategies and address specific needs and preferences across different markets. With a report timeline extending from 2020 to 2030, stakeholders gain insights into the market's past performance, current trends, and future projections, facilitating informed decision-making and strategic planning to capitalize on emerging opportunities and mitigate risks in the global pressure ulcers treatment market.
Global Pressure Ulcers Treatment Segment Analysis
In this report, the Global Pressure Ulcers Treatment Market has been segmented by Treatment Type, Type of Wound, End Users and Geography.
Global Pressure Ulcers Treatment Market , Segmentation by Treatment Type
The Global Pressure Ulcers Treatment Market has been segmented by Treatment Type into Wound Care Dressings, Wound Care Devices, Active Therapies and Others.
This segmentation highlights various modalities and products utilized in pressure ulcer care, catering to the specific needs and preferences of patients and healthcare providers.
One key segment within the pressure ulcers treatment market is wound care dressings, encompassing a range of products designed to promote wound healing and prevent infection. These include antimicrobial dressings, which help combat bacterial colonization in the wound bed, foam dressings offering absorbency and cushioning, hydrocolloid dressings providing a moist healing environment, film dressings offering a protective barrier, alginate dressings for highly exuding wounds, hydrogel dressings maintaining a moist wound environment, and other dressings catering to specific wound characteristics and patient requirements.
Another vital segment is wound care devices, featuring advanced technologies aimed at enhancing wound healing outcomes. Negative pressure wound therapy (NPWT) stands out as a prominent modality, utilizing controlled suction to remove excess exudate and promote granulation tissue formation. Additionally, ultrasound therapy holds promise in stimulating tissue repair and reducing inflammation, while other modalities like hyperbaric oxygen therapy (HBOT) and electromagnetic therapy offer alternative approaches to wound healing.
Active therapies constitute a significant segment in the pressure ulcers treatment market, encompassing interventions aimed at accelerating wound healing processes. This includes skin grafts and substitutes, which provide structural support and promote tissue regeneration, as well as growth factors that stimulate cell proliferation and angiogenesis. Other active therapies such as hemostatic agents and sealants, including collagen and fibrin sealants, contribute to hemostasis and tissue sealing, facilitating the healing process.
By segmenting the pressure ulcers treatment market based on treatment type, stakeholders gain insights into the diverse array of products and modalities available, enabling them to tailor interventions to individual patient needs and optimize clinical outcomes. This segmentation facilitates targeted research and development efforts, strategic marketing initiatives, and healthcare delivery strategies, ultimately improving the standard of care for pressure ulcer management globally.
Global Pressure Ulcers Treatment Market , Segmentation by Type of Wound
The Global Pressure Ulcers Treatment Market has been segmented by Type of Wound into Stage 1, Stage 2, Stage 3 and Stage 4.
The segmentation of the global pressure ulcers treatment market by the type of wound offers a granular understanding of how different treatment modalities align with the varying severity and characteristics of pressure ulcers. This segmentation enables healthcare providers and stakeholders to tailor interventions more precisely to the specific needs of patients at different stages of pressure ulcer development.
One significant segment in this market is stage-based classification, dividing pressure ulcers into stages 1 through 4 based on their severity and tissue involvement. Stage 1 ulcers represent the mildest form, characterized by non-blanchable erythema of intact skin, while stage 4 ulcers are the most severe, involving full-thickness tissue loss with exposed bone, tendon, or muscle. Intermediate stages 2 and 3 involve partial-thickness skin loss and full-thickness tissue loss without or with undermining or tunneling, respectively. By segmenting the market according to wound stage, healthcare providers can tailor treatment plans to address specific wound characteristics and promote optimal healing outcomes.
Segmentation by wound type may also consider other factors such as location, size, and presence of complicating factors like infection or necrosis. For example, pressure ulcers occurring over bony prominences like the sacrum or heels may require specialized interventions to alleviate pressure and promote tissue perfusion. Additionally, large or complex wounds may necessitate advanced therapies such as surgical debridement, flap reconstruction, or bioengineered skin substitutes. By segmenting the market based on these parameters, healthcare providers can select appropriate treatment modalities and allocate resources effectively to manage pressure ulcers comprehensively.
Understanding the distribution of pressure ulcers across different patient populations, such as geriatric, immobile, or critically ill individuals, can further inform treatment strategies and resource allocation. For instance, elderly patients with multiple comorbidities may require interdisciplinary care approaches to address both medical and social determinants of pressure ulcer development. By segmenting the market based on patient demographics and clinical characteristics, healthcare providers can implement tailored prevention and treatment protocols to mitigate the burden of pressure ulcers and improve patient outcomes.
Global Pressure Ulcers Treatment Market , Segmentation by End Users
The Global Pressure Ulcers Treatment Market has been segmented by End Users into Hospital Inpatient Settings, Hospital Outpatient Settings, Community Health Centers and Home Health Care.
Segmentation of the global pressure ulcers treatment market by end users provides crucial insights into the diverse settings where pressure ulcer management occurs and helps tailor strategies to meet the specific needs of each sector. This segmentation recognizes the varied healthcare environments where patients receive treatment and underscores the importance of customized approaches to address unique challenges and opportunities.
One key segment in this market is hospital inpatient settings, comprising acute care facilities where patients receive treatment for pressure ulcers during hospitalization. These settings often involve multidisciplinary teams collaborating to provide comprehensive care, including wound assessment, specialized interventions, and rehabilitation services. Segmentation by hospital inpatient settings acknowledges the critical role of acute care providers in managing pressure ulcers, particularly in addressing complex cases and preventing complications during hospital stays.
Hospital outpatient settings represent another significant segment, encompassing outpatient clinics and specialized wound care centers within hospital campuses. These settings cater to patients requiring ongoing management of pressure ulcers after discharge from acute care or those seeking specialized wound care services on an outpatient basis. Segmentation by hospital outpatient settings recognizes the importance of continuity of care and the role of outpatient facilities in promoting wound healing, preventing recurrence, and optimizing patient outcomes.
Community health centers constitute a vital segment within the pressure ulcers treatment market, serving as primary care hubs for patients in local communities. These centers play a crucial role in early detection, prevention, and management of pressure ulcers, particularly among vulnerable populations with limited access to healthcare services. Segmentation by community health centers highlights the importance of primary care providers in promoting health equity and addressing disparities in pressure ulcer care across diverse patient populations.
Home health care represents a significant segment, encompassing services provided in patients' homes by skilled healthcare professionals or informal caregivers. Home-based pressure ulcer management involves a range of interventions, including wound care, patient education, and environmental modifications to prevent pressure ulcer recurrence. Segmentation by home health care acknowledges the growing trend towards home-based care and the importance of empowering patients and caregivers to participate actively in pressure ulcer management.
Global Pressure Ulcers Treatment Market, Segmentation by Geography
In this report, the Global Pressure Ulcers Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Pressure Ulcers Treatment Market Share (%), by Geographical Region, 2024
North America stands out as a prominent segment in the global pressure ulcers treatment market, characterized by advanced healthcare systems, robust regulatory frameworks, and high healthcare expenditure. The region benefits from a strong emphasis on evidence-based practice and quality improvement initiatives, driving adoption of innovative treatment modalities and best practices in pressure ulcer management. Segmentation by North America acknowledges the region's leadership in medical innovation and its pivotal role in shaping global trends in pressure ulcer care.
Europe represents another significant segment, comprising diverse healthcare systems across countries with varying levels of healthcare infrastructure and reimbursement policies. The region's aging population and high prevalence of chronic diseases contribute to the burden of pressure ulcers, prompting investments in preventive measures and advanced wound care technologies. Segmentation by Europe recognizes the region's commitment to patient safety and quality of care, driving demand for effective pressure ulcer treatments and driving market growth.
Asia Pacific emerges as a rapidly growing segment in the global pressure ulcers treatment market, fueled by increasing healthcare spending, rising awareness of pressure ulcer prevention, and improving access to healthcare services in emerging economies. The region's large and diverse population presents unique challenges and opportunities for pressure ulcer management, with a growing emphasis on community-based care and telemedicine solutions. Segmentation by Asia Pacific acknowledges the region's potential as a key market for pressure ulcer treatment and highlights the importance of culturally sensitive approaches to care delivery.
In the Middle East and Africa (MEA), the pressure ulcers treatment market is characterized by a diverse healthcare landscape, encompassing countries with varying levels of economic development, healthcare infrastructure, and healthcare expenditure. In many parts of the region, access to advanced wound care products and specialized services may be limited, particularly in rural and underserved areas.
In Latin America, the pressure ulcers treatment market is shaped by similar challenges, including socioeconomic disparities, unequal access to healthcare services, and a high burden of chronic diseases. While some countries in the region boast relatively advanced healthcare systems and a growing market for medical devices and wound care products, others face significant barriers to effective pressure ulcer management, such as limited healthcare infrastructure and workforce shortages. Segmentation by Latin America recognizes the region's diversity and underscores the importance of tailored approaches to pressure ulcer prevention and treatment, taking into account the unique needs and challenges of individual countries and communities.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Pressure Ulcers Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis,
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population
- Chronic Diseases
- Technological Innovations
-
Healthcare Infrastructure - The healthcare infrastructure plays a pivotal role in shaping the landscape of the global pressure ulcers treatment market, influencing access to care, quality of services, and treatment outcomes. Across different regions, the state of healthcare infrastructure varies widely, ranging from highly developed systems in countries with robust economies to resource-constrained settings in low- and middle-income nations. The availability of healthcare facilities, including hospitals, clinics, and specialized wound care centers, significantly impacts patients' ability to receive timely and effective treatment for pressure ulcers.
In regions with advanced healthcare infrastructure, such as North America and Europe, patients benefit from comprehensive healthcare systems equipped with state-of-the-art medical technologies, well-trained healthcare professionals, and established protocols for pressure ulcer management. These regions often have dedicated wound care clinics and multidisciplinary teams specializing in wound management, facilitating prompt diagnosis, tailored treatment plans, and ongoing monitoring of pressure ulcers. Moreover, advanced healthcare infrastructure enables seamless coordination between primary care providers, specialists, and allied health professionals, ensuring continuity of care and optimizing patient outcomes.
In many parts of the world, particularly in low-resource settings in Asia, Africa, and Latin America, healthcare infrastructure may be inadequate to meet the growing burden of pressure ulcers effectively. Limited access to healthcare facilities, shortage of skilled healthcare professionals, and lack of essential medical supplies pose significant challenges to pressure ulcer management in these regions. Despite these challenges, efforts are underway to strengthen healthcare infrastructure, expand access to essential healthcare services, and improve the quality of wound care through capacity building initiatives, technology transfer programs, and partnerships with international organizations. By addressing gaps in healthcare infrastructure, policymakers and stakeholders aim to enhance the delivery of pressure ulcer treatment and reduce disparities in access to care globally.
Restraints
- Limited Awareness
- High Treatment Costs
- Lack of Access to Healthcare
-
Resource Constraints - Resource constraints pose significant challenges to the global pressure ulcers treatment market, particularly in regions with limited healthcare infrastructure and financial resources. These constraints encompass shortages of essential medical supplies, equipment, and trained healthcare professionals, hindering the delivery of timely and effective care to patients with pressure ulcers. In resource-constrained settings, healthcare facilities may struggle to procure advanced wound care products, diagnostic tools, and therapeutic modalities needed for optimal pressure ulcer management, leading to suboptimal treatment outcomes and increased risk of complications.
Moreover, financial limitations restrict investment in healthcare infrastructure, including the establishment of specialized wound care centers, procurement of medical equipment such as pressure-relieving mattresses and negative pressure wound therapy devices, and training of healthcare personnel in evidence-based wound care practices. The high cost associated with pressure ulcer treatment, including hospitalization, surgical interventions, and long-term care, exacerbates the financial burden on healthcare systems and patients, further exacerbating resource constraints.
Resource constraints also impact preventive measures aimed at reducing the incidence and severity of pressure ulcers. Adequate staffing levels, education programs for patients and caregivers, and implementation of pressure ulcer prevention protocols may be lacking in resource-constrained settings, contributing to higher rates of pressure ulcer development and recurrence. Addressing resource constraints requires coordinated efforts from policymakers, healthcare providers, and stakeholders to prioritize healthcare investments, optimize resource allocation, and implement cost-effective strategies for pressure ulcer prevention and treatment, ultimately improving patient outcomes and reducing the burden on healthcare systems.
Opportunities
- Emerging Markets
- Technological Innovations
- Increasing Healthcare Expenditure
-
Aging Population - The aging population represents both a driver and a challenge for the global pressure ulcers treatment market. As the world's population continues to age, particularly in developed regions like North America, Europe, and parts of Asia, the prevalence of pressure ulcers is expected to rise. Aging is often accompanied by factors such as reduced mobility, chronic illnesses, and changes in skin integrity, all of which increase the risk of developing pressure ulcers. Consequently, the aging population fuels the demand for pressure ulcer treatment and management, driving market growth.
The aging population also presents challenges for pressure ulcer management. Elderly individuals are more susceptible to pressure ulcers due to factors such as thinning skin, decreased subcutaneous tissue, and impaired circulation. Moreover, comorbidities common among the elderly, such as diabetes, peripheral vascular disease, and neurological disorders, further increase the risk of pressure ulcer development and complicate treatment. The complex healthcare needs of the aging population place a significant strain on healthcare systems, necessitating comprehensive approaches to pressure ulcer prevention, early detection, and intervention.
To address the challenges posed by the aging population, healthcare providers and stakeholders must prioritize preventive measures and implement evidence-based interventions tailored to the unique needs of elderly patients. This includes regular skin assessments, mobilization protocols, nutrition optimization, and education initiatives targeting both healthcare professionals and caregivers. Additionally, technological innovations, such as pressure-relieving surfaces and wearable sensors for continuous monitoring, offer promising solutions for pressure ulcer prevention and early detection in the aging population. By adopting holistic approaches to pressure ulcer management, healthcare systems can effectively address the needs of the aging population and improve outcomes for elderly individuals at risk of pressure ulcers.
Competitive Landscape Analysis
Key players in Global Pressure Ulcers Treatment Market include;
- Smith & Nephew plc
- Integra LifeSciences Corporation
- Hill-Rom Holdings, Inc.
- Mölnlycke Health Care AB
- Essity Aktiebolag
- Cardinal Health
- 3M Healthcare
- B. Braun Melsungen AG
- Acelity L.P., Inc.
- Coloplast Group
- ConvaTec
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Type of Wound
- Market Snapshot, By End Users
- Market Snapshot, By Region
- Global Pressure Ulcers Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Chronic Diseases
- Technological Innovations
- Healthcare Infrastructure
- Restraints
- Limited Awareness
- High Treatment Costs
- Lack of Access to Healthcare
- Resource Constraints
- Opportunities
- Emerging Markets
- Technological Innovations
- Increasing Healthcare Expenditure
- Aging Population
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Pressure Ulcers Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Wound Care Dressings
- Antimicrobial Dressings
- Foam Dressings
- Hydrocolloid Dressings
- Film Dressings
- Alginate Dressings
- Hydrogel Dressings
- Other Dressings
- Wound Care Devices
- Negative Pressure Wound Therapy (NPWT)
- Ultrasound Therapy
- Others (HBOT and electromagnetic therapy)
- Active Therapies
- Skin Grafts & Substitutes
- Growth Factors
- Others (hemostatic agents, sealants (collagen and fibrin sealants))
- Others
- Traditional Wound Care Products
- Pressure Relief Devices
- Others
- Wound Care Dressings
- Global Pressure Ulcers Treatment Market, By Type of Wound, 2021 - 2031 (USD Million)
- Stage 1
- Stage 2
- Stage 3
- Stage 4
- Global Pressure Ulcers Treatment Market, By End Users, 2021 - 2031 (USD Million)
- Hospital Inpatient Settings
- Hospital Outpatient Settings
- Community Health Centers
- Home Health Care
- Global Pressure Ulcers Treatment Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Pressure Ulcers Treatment Market, By Treatment Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Smith & Nephew plc
- Integra LifeSciences Corporation
- Hill-Rom Holdings, Inc.
- Mölnlycke Health Care AB
- Essity Aktiebolag
- Cardinal Health
- 3M Healthcare
- B. Braun Melsungen AG
- Acelity L.P., Inc.
- Coloplast Group
- ConvaTec
- Company Profiles
- Analyst Views
- Future Outlook of the Market